Day 1 :
Yokohama University of Pharmacy, Japan
Keynote: EFdA: An extremely excellent anti-HIV nucleoside from design to the current clinical trial results
Hiroshi Ohrui has completed his PhD in Organic Chemistry at the University of Tokyo and Postdoctoral studies at Sloan-Kettering Institute for Cancer Research and Syntex Research. He has worked at Riken and Tohoku University and received several awards including The Japan Society for Analytical Chemistry Award and Japan Academy Prize.
Ali O Kilic
Karadeniz Technical University, Turkey